This is How Effective the Pfizer and Moderna Covid Vaccines Are for the Elderly

According to a Centers for Disease Control and Prevention (CDC) study that was published this Wednesday, the Covid vaccines from Pfizer and Moderna are 94% effective at preventing hospitalizations in the elderly.

The Pfizer-BioNTech and Moderna Covid-19 vaccines were found to be 94% effective at preventing hospitalizations among people ages 65 and over in the real-world CDC study.

The study had also found that the two-dose mRNA vaccines were 64% effective at preventing hospitalizations in the elderly who received just one shot.

The CDC said these findings were consistent with those found in clinical trials.

“This multisite U.S. evaluation under real-world conditions suggests that vaccination provided protection against COVID-19–associated hospitalization among adults aged ≥65 years,” the CDC wrote in the study. “Vaccination is a critical tool for reducing severe COVID-19 in groups at high risk.”

According to data that has been compiled by Johns Hopkins University, at least 573,420 Americans have died from Covid-19 and over 32.1 million have been infected.

As of Tuesday this week, over 81% of U.S. adults ages 65 and older have received at least one dose of a Covid-19 vaccine, according to data compiled by the CDC.

More than 67% of U.S. adults ages 65 and older are fully vaccinated, the CDC has reported.

In a statement Wednesday, CDC Director Dr. Rochelle Walensky said the agency’s findings were “encouraging and welcome news.”

“The results are promising for our communities and hospitals,” she added. “As our vaccination efforts continue to expand, COVID-19 patients will not overwhelm health care systems — leaving hospital staff, beds, and services available for people who need them for other medical conditions.”

White House chief medical advisor Dr. Anthony Fauci said this week that Americans should begin to see a turning point in the pandemic “within a few weeks.”

If the country continues its vaccination pace, “literally within a few weeks, we’re going to start to see a turning around of the dynamics,” Fauci said Monday during a virtual event hosted by the Harvard T.H. Chan School of Public Health.

“Not down to no infections,” he also added. “If you’re waiting for classic measles-like herd immunity, that’s going to be a while before we get there. But that doesn’t mean we’re not going to have a significant diminution in the number of infections per day and a significant diminution in all of the parameters, namely hospitalizations and deaths.”

Disclaimer: We have no position in any of the companies mentioned and have not been compensated for this article.